Found 6 matching trials
A Study of CTX-009 (ABL001) in Combination With Irinotecan or Paclitaxel in Advanced or Metastatic Solid Tumor Patients PHASE1 This study is a Phase 1b/2 multi-center study to assess the safety, tolerab...
Show More Location
Seoul National University Bundang Hospital
Learn More & Join Trial
A Study of CTX-009 in Adult Patients With Metastatic Colorectal Cancer PHASE2 This study is designed as an open-label, adaptive Simon Two-Stage study to ...
Show More Location
Genesis Cancer and Blood Institute
Learn More & Join Trial
Safety and Efficacy of CTX-009 With or Without CTX-471 for Recurrent Glioblastoma PHASE1 This is a phase IB/II, open-label study evaluating CTX-009 as monotherapy a...
Show More Location
Washington University School of Medicine
Learn More & Join Trial
CTX-009 With Gemcitabine, Cisplatin, and Durvalumab as First-line Therapy in Patients With Unresectable or Metastatic Biliary Tract Cancers PHASE1 To evaluate combination therapy of adding CTX-009 to the standard therapy G...
Show More Location
MD Anderson Cancer Center
Learn More & Join Trial
A Study of CTX-009 in Combination With Paclitaxel in Adult Patients With Unresectable Advanced, Metastatic or Recurrent Biliary Tract Cancers (COMPANION-002) PHASE2 This is a multi-center, open-label, randomized, phase 2/3 trial of the bisp...
Show More Status
Active Not Recruiting
Location
Mayo Clinic Arizona
Learn More & Join Trial
Tovecimig Plus FOLFIRI in Second Line Metastatic Colorectal Cancer PHASE2 This is an open-label Phase 2 study to evaluate the safety and efficacy of ...
Show More Location
Washington University School of Medicine
Learn More & Join Trial